East Windsor, NJ—A new comprehensive book about curcumin is now available. Written by Muhammed Majeed, Ph.D., founder of Sabinsa Corp., and co-authors, Curry Powder to Clinical Significance (NutriScience Publishers, 2015) discusses the clinical use of curcumin and the history of Sabinsa’s Curcumin C3 Complex.

The two-part book begins with a discussion of curcumin chemistry by Bharat B. Aggarwal, Ph.D., of Cytokine Research Laboratory and the University of Texas MD Anderson Cancer Center. Aggarwal then covers curcumin’s role in several aspects of health, such as serving as an anti-inflammatory agent (inhibiting NF-KB, COX-2, STAT3 and TNF-a), an immune system modulator (inhibiting adhesion molecules and cytokine expression), an antioxidant, an anti-cancer agent and more. He states, “All these studies from our group indicated that the Curcumin derived from golden spice exhibits multiple biological activities. It is a multi-targeted agent that is highly safe and thus, should be explored further in the clinic.”

Part Two, written by Majeed and his scientific team, chronicles the numerous clinical trials completed on Curcumin C3 Complex, and offers a thorough discussion of curcumin’s bioavailability. Majeed writes, “It has become fashionable for people including eminent scientists to start any discussion on Curcumin with its purported poor bioavailability.” Majeed and colleagues address this issue and discuss the potential of nature-derived co-crystals in the curcumin market.

Published in WholeFoods Magazine, February 2016 (online 12/31/15)